drug · small molecule
EPIPEN E Z PEN
updated 5mo agoby $VTRS Viatris Inc🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- drugLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE605 co-mentions · 153 sources
- drugEPINEPHRINE586 co-mentions · 154 sources
- tagApproval556 co-mentions · 141 sources
- drugepinephrine Fresenius455 co-mentions · 153 sources
- drugadrenaline455 co-mentions · 153 sources
- druglidocaine SR163 co-mentions · 81 sources
- drugLIDOCAINE163 co-mentions · 81 sources
- drugLIDOCAINE HYDROCHLORIDE153 co-mentions · 77 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 19 approved and 33 investigational indications.
targets
Adrenergic receptor
all catalysts(0)
nothing on the calendar yet
Trials studying EPIPEN E Z PEN
- phase2An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
- phase2A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)
- phase3Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- phase2A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
- phase1PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
- phase2Phase 2B Upper Extremity Nerve Block Study
- phase4Epinephrine Dose: Optimal Versus Standard Evaluation Trial
- phase2Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
News(3)
- American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of SterilityFOR IMMEDIATE RELEASE – September 3, 2026 – New Albany, OH, American Regent, Inc. is conducting a nationwide voluntary recall of three lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) mult…fda_recalls · 28d ago
- Chutes & Ladders—Legend CEO departs without successor in placeLegend Biotech CEO Ying Huang, Ph.D., has left the company suddenly, without a predecessor in place. Huang was elevated from CFO to CEO in 2020 after a Chinese customs investigation was opened on f…fiercebiotech · 2mo ago
- Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs“We're basically not using our body as directed,” says "Drug Story" host Thomas Goetz.stat · 5mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that